Symbol
| ATP2B2
| contributors: npt/mct/pgu - updated : 15-11-2016
|
HGNC name
| ATPase, Ca++ transporting, plasma membrane 2
|
HGNC id
| 815
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
| germinal mutation
|  
|  
|  
|
with mutation of CDH23, leading to sensorineural deafness | constitutional
|  
|  
| --low
|  
|
down-regulated early in mammary involution associated with changes in mammary epithelial cell shape | tumoral
|  
|  
| --over
|  
|
in breast cancers is associated with poor outcome | constitutional
|  
|  
| --low
|  
|
such as occurs in aging brain likely leads to subtle disruptions in normal Ca(2+) signaling and enhanced susceptibility to stresses that can alter the regulation of Ca(2+) homeostasis | |
Variant & Polymorphism
| variant may modify the severity of sensorineural hearing loss caused by a variety of factors |
|
|
Candidate gene
| for sensorineural hearing loss in 3p25 deletion |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | breast | |
interactions between ATP2B2 and ERBB2 may represent therapeutic targets for breast cancer | cancer | reproductive | breast | |
interactions between ATP2B2 and ERBB2 may represent therapeutic targets for breast cancer |
| | |
| mouse mutation, Tommy, causes a non-conservative Glu629Lys change in the second intracellular loop of the pump which harbors the active site, leading to profound hearing impairment from P18, with significant differences in hearing thresholds between wild type and heterozygotes | |
Atp2b2 murine mutant overexpressed in model cells displayed an evident defect both in the basal activity of the pump and in the long range ejection of Ca(2+), the human mutant instead failed to impair the Ca(2+) ejection by the pump |